A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
ABSTRACT Lassa virus (LASV) poses a significant public health problem within the regions of Lassa fever endemicity in Western Africa. LASV infects several hundred thousand individuals yearly, and a considerable number of Lassa fever cases are associated with high morbidity and lethality. No approved...
Enregistré dans:
Auteurs principaux: | Yingyun Cai, Masaharu Iwasaki, Daisuke Motooka, David X. Liu, Shuiqing Yu, Kurt Cooper, Randy Hart, Ricky Adams, Tracey Burdette, Elena N. Postnikova, Jonathan Kurtz, Marisa St. Claire, Chengjin Ye, Jens H. Kuhn, Luis Martínez-Sobrido, Juan Carlos de la Torre |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ff2f37fbb3974b63a94d0c00aaaa85fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
par: Yingyun Cai, et autres
Publié: (2020) -
Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus
par: Antonio Herrador, et autres
Publié: (2019) -
Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments
par: Christine E. Hulseberg, et autres
Publié: (2018) -
Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments
par: Hannah L. Murphy, et autres
Publié: (2021) -
Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever
par: Shuiyun Lan, et autres
Publié: (2020)